Trusted News Discovery Since 2008
{{/content}}
Tocilizumab Reduces Risk Of Death In Severe COVID-19 Patients
Video Credit: Wochit Tech
Published on October 22, 2020 - Duration: 00:32s
Tocilizumab Reduces Risk Of Death In Severe COVID-19 Patients
Treatment with the drug tocilizumab has been shown to reduce the risk of death among hospitalized patients with severe COVID-19.
Tocilizumab cuts the risk of death by about 30%, according to a study published Tuesday.
The medication, which also goes by the name Actmera is primarily used to treat rheumatoid arthritis.
The medication is an immunosuppressive drug designed to reduce inflammation.
You are here
Related videos from verified sources
Cognitive disorders linked to severe COVID-19 risk, suggests study 01:23
Video credit: ANI - Published on October 29, 2020
Flu Vaccine May Lower Risk Of Severe Illness From COVID-19 00:32
Video credit: Wochit - Published on October 29, 2020
Study Finds Taking Aspirin Significantly Lowers Risk Of Complications, Death In Coronavirus Patients 02:11
Video credit: WJZ Baltimore - Published on October 23, 2020